Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Recurrence 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid 2Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia 1Congenital Abnormalities 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Cytarabine 60Etoposide 24Daunorubicin 24Filgrastim 19Idarubicin 16Mitoxantrone 13Busulfan 12tipifarnib 11Gemtuzumab 10fludarabine phosphate 9Peripheral Blood Stem Cell Transplantation 9Cyclophosphamide 9Flow Cytometry 8Clofarabine 8Azacitidine 8sargramostim 7Methotrexate 7Gene Expression Profiling 7Topotecan 6Cyclosporine 6valspodar 5alvocidib 5Radiotherapy 5Granulocyte Colony-Stimulating Factor 5aldesleukin 4Observation 4Bortezomib 4Arsenic Trioxide 4Antilymphocyte Serum 4Whole-Body Irradiation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Myelomonocytic, Acute × zosuquidar trihydrochloride × Clear all
NCT00046930 2023-07-05

Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia

Eastern Cooperative Oncology Group

Phase 3 Completed
449 enrolled 9 charts
Classical hematologyMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡